FEB 17, 2020 8:51 AM PST

Another HIV vaccine attempt fizzles out

WRITTEN BY: Tara Fernandez

Years of work and over $100 million in study costs have been abandoned after an HIV-vaccine tested in South Africa failed to protect treated individuals against HIV infections.

Over 5000 uninfected adults had enrolled in the study, with half receiving a shot of the vaccine and the other half being injected with a placebo. Much to the dismay of the study’s researchers, a routine safety and efficacy check-in revealed extremely disappointing results: 129 people from the vaccinated group and 123 from the placebo-treated population were found to be HIV-positive. 

On receiving these shocking results, President of the South African Medical Research Council (MRC) and study chair, Glenda Gray said, “I was catatonic.”

The research, partly funded by the Bill & Melinda Gates Foundation, was part of ongoing efforts to try to curb South Africa’s HIV epidemic that has been spiraling out of control. Over 20 percent of the world’s HIV-infected populations reside in South Africa, where an effective vaccine would have been instrumental in limiting the spread of the virus. “The epidemic is out of control here and we have to take steps to have a biomedical intervention,” said Gray.

This setback comes after a similar study in Thailand, conducted in 2009, also showed discouraging levels of protection. With an efficacy rate of just over 30 percent, researchers and drug developers were divided on whether to pursue the commercialization of the vaccine. 

To date, a major knowledge gap exists in both our understanding of the molecular immune pathways activated during HIV infection which have hampered researchers’ race to develop vaccines. Some lab-tested strategies have used neutralizing antibodies to thwart HIV infections, but in human trials, these have been hit or miss.

Two more HIV vaccine trials are set to deliver results in the next few years. However, with the track record of vaccination failures, global health organizations are pinning their hopes on other preventative and therapeutic measures to address the global HIV crisis.


Source: Science.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 27, 2019
Immunology
NOV 27, 2019
Playing "Tag" with the Immune System
Human cells employ an intricate tagging system to manage protein activity in the body. By “tagging” a protein with a certain modification, cell...
DEC 04, 2019
Neuroscience
DEC 04, 2019
Antibiotic Usage May Cause Parkinson's, Study Finds
A study from Helsinki University Hospital, Finland suggests that excessive usage of certain antibiotics may increase one’s risk of developing Parkins...
DEC 31, 2019
Genetics & Genomics
DEC 31, 2019
Should the Scientist Behind World's First Gene Edited Babies be in Prison?
He Jiankui, the scientist behind the world’s first gene-edited babies in 2018, has been sentenced to three years in prison by Chinese authorities for...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
Potential Cure for Coronavirus Found in Thailand
Doctors in Thailand have successfully treated people affected by the coronavirus via a new drug cocktail made out of antiviral, flu and HIV medication. Alt...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
FDA Approves 5-Minute Coronavirus Test
In recent weeks, the US has struggled to supply enough tests to detect the coronavirus. Now, however, this may change thanks to the FDA’s approval of...
APR 01, 2020
Immunology
APR 01, 2020
New Airway-Hugging Immune Cells Discovered in the Lung
  Scientists have discovered a previously unknown subset of immune cells residing in the lung that specifically combat viral infections. The respirato...
Loading Comments...